Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Journal of Neurology
Nature Genetics ; Volume: 56 ; Page: 395-407
Médecine/Sciences ; Volume: 40 ; Page: 133-136
M/S : médecine / sciences ; Volume: 39 ; Page: 32-36
Brain - A Journal of Neurology ; Volume: 146 ; Page: 4158-4173
Molecular Therapy - Nucleic Acids ; Volume: 33 ; Page: 321-334
Circulation Research ; Volume: 132 ; Page: e188-e205
JCI Insight ; Volume: 8 ; Page: e151933
Current Opinion in Pharmacology ; Volume: 68 ; Page: 102328
Brain - A Journal of Neurology
Current fundings:
Her work, supervised by Jocelyn Laporte (IGBMC) and Julie Thompson (ICUBE), is entitled: “Multiscale characterization of rare genetic diseases through…
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: